See also this year's filing and all EDGAR filings for this company.
PDF Report 0001023024_2020_ANI_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001023024, ANI Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 187,695,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 183,968,000 |
| 2 | PropertyPlantAndEquipmentNet | 40,551,000 |
| 3 | remainder_Assets | 44,575,000 |
| 4 | LiabilitiesCurrent | 61,676,000 |
| 5 | LiabilitiesNoncurrent | 182,322,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 55,613,634 |
| 8 | SellingGeneralAndAdministrativeExpense | 88,014,144 |
| 9 | ResearchAndDevelopmentExpense | 18,933,405 |
| 10 | remainder_Expenses | 53,059,000 |
| 11 | remainder_Revenues | 220,944,687 |
| 12 | remainder_NetIncome | -13,388,731 |
| 13 | remainder_ComprehensiveNetIncome | -25,057,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 456,789,000 |
| 1 | Liabilities | 243,998,000 |
| 2 | Expenses | 215,620,183 |
| 3 | Revenues | 220,944,687 |
| 4 | StockholdersEquity | 212,791,000 |
| 5 | NetIncome | -8,064,227 |
| 6 | ComprehensiveNetIncome | -20,592,727 |
| 7 | BaseVar | 587,898,800 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.27 |
| 9 | EconomicCapitalRatio | 2.51 |
Edgar->Model Mapping
Feature Distribution
Change over Time
